Results
1
1 companies
ALTEOGEN
Market Cap: ₩15.5t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩288,500.00
7D
-8.0%
1Y
-40.6%
